ABO Discrepancy in Multiple Myeloma Initially Suspected as a Complication of COVID-19 Vaccination.

Publication date: May 01, 2026

The effect of COVID-19 infection and its vaccines on the immune system is still a subject of much research and debate. Caution is warranted to rule out known entities before considering these possibilities. We report a case of an incidentally detected ABO discrepancy initially suspected to be temporally associated with COVID-19 vaccination but diagnosed ultimately as multiple myeloma. A 52-year-old male patient presented with weakness, easy fatigability, and chest pain following the second dose of the COVID-19 vaccine. His hemoglobin fell progressively, and he was advised blood transfusion. Blood grouping revealed an ABO discrepancy in forward and reverse grouping. The initial indirect Coombs test (ICT) showed 3+ reactivity, possibly due to non-specific interference from elevated serum proteins, but the repeat test was negative. Routine peripheral blood smear examination showed rouleaux formation and background blue-tinging. Saline replacement dispersed the RBC aggregates, confirming pseudo-agglutination. The patient also had a raised erythrocyte sedimentation rate (ESR). The patient was suspected of having a plasma cell dyscrasia, which was confirmed on serum electrophoresis, and this explained the ABO discrepancy. M protein in plasma cell myeloma is known to cause group III ABO discrepancy due to rouleaux formation, which can be interpreted as pseudo-agglutination and can be a presenting feature. Though temporal association with vaccination may raise suspicion, a detailed work-up is necessary to avoid misattribution and missing underlying disease.

Open Access PDF

Concepts Keywords
Covid abo blood group
Misattribution abo discrepancy
Myeloma coomb’s test
Vaccine covid 19 vaccination
plasma cell myeloma

Semantics

Type Source Name
disease MESH Multiple Myeloma
disease MESH COVID-19
disease MESH infection
pathway REACTOME Immune System
disease MESH chest pain
disease MESH plasma cell dyscrasia
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH Allergy
disease MESH autoimmune diseases
disease MESH syndrome
disease MESH macroglobulinemia
disease MESH Hodgkin’s lymphoma
disease MESH anemia
disease MESH macrocytic anemia
disease MESH leukopenia
disease MESH thrombocytopenia
drug DRUGBANK Albendazole
disease MESH hypercalcemia
disease MESH renal failure
disease MESH fever
disease MESH pain
disease MESH fatigue
disease MESH myocarditis
disease MESH hematologic malignancies
disease MESH back pain
disease MESH viral infections
disease MESH autoimmune hemolytic anemia
disease MESH hemolysis
disease MESH reticulocytosis
disease MESH bone disease
disease MESH immune thrombocytopenia
disease MESH severe acute respiratory syndrome
disease MESH coronavirus infection

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *